 BRYAN, Texas, Dec. 06, 2022 GLOBE NEWSWIRE iBio, Inc. NYSEA: IBIO iBio or the Company, an AI-driven innovator of precision antibody immunotherapies, today announced the pricing of its previously announced underwritten public offering of an aggregate of 3,365,385 shares of its common stock or pre-funded warrants in lieu thereof, Series A warrants to purchase ... The post iBio Announces Pricing of 3.5 Million Underwritten Public Offering appeared first on ForexTV... 